Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
I-MAK UPDATE: I-MAK filed two additional patent challenges against @GileadSciences #HepC treatment Sovaldi. Our challenges against 8 patents could bring generics to U.S. 16 years faster. 12:49 - 06 Dec 2017